Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 2806 AL 2820

Dyskinesia and Parkinson's disease: animal model, drug targets, and agents in preclinical testing

Cesaroni V, Blandini F, Cerri S.

Expert Opin Ther Targets. 2022 Oct;26(10):837-851. doi: 10.1080/14728222.2022.2153036. Epub 2022 Dec 13.

Mitochondrial dysfunction of induced pluripotent stem cells-based neurodegenerative disease modeling and therapeutic strategy

Luo HM, Xu J, Huang DX, Chen YQ, Liu YZ, Li YJ, Chen H.

Front Cell Dev Biol. 2022 Nov 21;10:1030390. doi: 10.3389/fcell.2022.1030390. eCollection 2022.

Wolff-Parkinson-White Syndrome and Peripartum Cardiomyopathy

Ghaderian M, Movahedi M, Sabri MR, Dehghan B, Ahmadi A, Mahdavi C, Nejad DR, Esnaashari A.

Heart Views. 2022 Jul-Sep;23(3):173-176. doi: 10.4103/heartviews.heartviews_13_22. Epub 2022 Oct 22.

Effects of a forced cycling program with cognitive stimulation on symptomatology, physical condition, and cognition in people diagnosed with Parkinson disease

Pereira-Pedro KP, de Oliveira IM, Mollinedo Cardalda I, Cancela-Carral JM.

Medicine (Baltimore). 2022 Dec 2;101(48):e31920. doi: 10.1097/MD.0000000000031920.

Editorial: Role of metal ions in central nervous system: Physiology and pathophysiology

Guo F, Zylinska L, Boczek T.

Front Cell Neurosci. 2022 Nov 22;16:1093224. doi: 10.3389/fncel.2022.1093224. eCollection 2022.

Typical imaging manifestation of neuronal intranuclear inclusion disease in a man with unsteady gait: A case report

Gao X, Shao ZD, Zhu L.

World J Clin Cases. 2022 Nov 26;10(33):12388-12394. doi: 10.12998/wjcc.v10.i33.12388.

Emerging point-of-care autologous cellular therapy using adipose-derived stromal vascular fraction for neurodegenerative diseases

Al-Kharboosh R, Perera JJ, Bechtle A, Bu G, Quinones-Hinojosa A.

Clin Transl Med. 2022 Dec;12(12):e1093. doi: 10.1002/ctm2.1093.

Levodopa-Induced Dyskinesia in Parkinson's Disease: Pathogenesis and Emerging Treatment Strategies

Kwon DK, Kwatra M, Wang J, Ko HS.

Cells. 2022 Nov 23;11(23):3736. doi: 10.3390/cells11233736.

Iron Brain Menace: The Involvement of Ferroptosis in Parkinson Disease

Lin KJ, Chen SD, Lin KL, Liou CW, Lan MY, Chuang YC, Wang PW, Lee JJ, Wang FS, Lin HY, Lin TK.

Cells. 2022 Nov 29;11(23):3829. doi: 10.3390/cells11233829.

Open Questions on the Electromagnetic Field Contribution to the Risk of Neurodegenerative Diseases

Wyszkowska J, Pritchard C.

Int J Environ Res Public Health. 2022 Dec 2;19(23):16150. doi: 10.3390/ijerph192316150.

Emerging Roles for the RNA-Binding Protein HuD (ELAVL4) in Nervous System Diseases

Silvestri B, Mochi M, Garone MG, Rosa A.

Int J Mol Sci. 2022 Nov 23;23(23):14606. doi: 10.3390/ijms232314606.

Pathogenesis of α-Synuclein in Parkinson's Disease: From a Neuron-Glia Crosstalk Perspective

Yi S, Wang L, Wang H, Ho MS, Zhang S.

Int J Mol Sci. 2022 Nov 25;23(23):14753. doi: 10.3390/ijms232314753.

Antibodies against HSV-1 and Curli Show the Highest Correlation in Parkinson's Disease Patients in Comparison to Healthy Controls

Jasemi S, Paulus K, Noli M, Simula ER, Ruberto S, Sechi LA.

Int J Mol Sci. 2022 Nov 26;23(23):14816. doi: 10.3390/ijms232314816.

Neuroinflammation and Autophagy in Parkinson's Disease-Novel Perspectives

Minchev D, Kazakova M, Sarafian V.

Int J Mol Sci. 2022 Nov 30;23(23):14997. doi: 10.3390/ijms232314997.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias